These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1946520)

  • 1. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemically induced cell proliferation in liver carcinogenesis.
    Popp JA; Marsman DS
    Prog Clin Biol Res; 1991; 369():389-95. PubMed ID: 1946534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.
    Menegazzi M; Carcereri-De Prati A; Suzuki H; Shinozuka H; Pibiri M; Piga R; Columbano A; Ledda-Columbano GM
    Hepatology; 1997 Mar; 25(3):585-92. PubMed ID: 9049203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hepatocyte proliferation in regeneration, augmentative hepatomegaly, and neoplasia.
    Michalopoulos G
    Prog Clin Biol Res; 1991; 369():227-36. PubMed ID: 1946521
    [No Abstract]   [Full Text] [Related]  

  • 6. Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens.
    Columbano A; Ledda-Columbano GM; Lee G; Rajalakshmi S; Sarma DS
    Cancer Res; 1987 Nov; 47(21):5557-9. PubMed ID: 2889525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of hepatocytes to the effect of factors stimulating and suppressing cell proliferation in hepatocarcinogenesis].
    Osipova LA
    Eksp Onkol; 1984; 6(2):23-6. PubMed ID: 6510330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hyperplasia in liver carcinogenesis.
    Mirsalis JC; Steinmetz KL
    Prog Clin Biol Res; 1990; 331():149-61. PubMed ID: 2179957
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha.
    Shinozuka H; Ohmura T; Katyal SL; Zedda AI; Ledda-Columbano GM; Columbano A
    Hepatology; 1996 Jun; 23(6):1572-7. PubMed ID: 8675179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
    Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
    Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 13. Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.
    Ledda-Columbano GM; Coni P; Simbula G; Zedda I; Columbano A
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):163-8. PubMed ID: 8013404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms of liver tumor promotion.
    Williams GM
    Prog Clin Biol Res; 1990; 331():131-45; discussion 147-8. PubMed ID: 2179956
    [No Abstract]   [Full Text] [Related]  

  • 15. The cellular analysis of liver carcinogenesis: ultrastructural alterations within hyperplastic liver nodules induced by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Caito BJ; Bartus B
    Cancer Res; 1967 Sep; 27(9):1712-21. PubMed ID: 6051282
    [No Abstract]   [Full Text] [Related]  

  • 16. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
    Cattley RC; Miller RT; Corton JC
    Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes.
    Mayol X; Neal GE; Davies R; Romero A; Domingo J
    Carcinogenesis; 1992 Dec; 13(12):2381-8. PubMed ID: 1361882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation.
    Jirtle RL; Meyer SA; Brockenbrough JS
    Prog Clin Biol Res; 1991; 369():209-16. PubMed ID: 1946518
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP.
    Columbano A; Ledda-Columbano GM; Pibiri M; Piga R; Shinozuka H; De Luca V; Cerignoli F; Tripodi M
    Oncogene; 1997 Feb; 14(7):857-63. PubMed ID: 9047393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead-induced cell proliferation and organ-specific tumorigenicity.
    Calabrese EJ; Baldwin LA
    Drug Metab Rev; 1992; 24(3):409-16. PubMed ID: 1628538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.